Hong Kong stocks surge | WuXi Biologics (02269.HK) rises by over 6% again, the company expects a year-on-year increase of over 56% in net profit in the first half of the year. Morgan Stanley says its first-half financial report exceeded expectations.
Wisdom Finance and Economics APP learned that WuXi Biologics (02269.HK) has surged over 6% again. As of the time of writing, it has increased by 5.86%, reaching 31.6 Hong Kong dollars, with a transaction amount of 8.2 billion Hong Kong dollars.
Latest
